Renaissance Group’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-99,572
| Closed | -$3.7M | – | 243 |
|
|
2024
Q4 | $3.7M | Buy |
99,572
+29,696
| +42% | +$1.1M | 0.15% | 120 |
|
|
2024
Q3 | $3.39M | Buy |
69,876
+4,858
| +7% | +$236K | 0.14% | 118 |
|
|
2024
Q2 | $2.6M | Buy |
65,018
+5,616
| +9% | +$225K | 0.1% | 171 |
|
|
2024
Q1 | $2.61M | Buy |
59,402
+10,983
| +23% | +$482K | 0.1% | 167 |
|
|
2023
Q4 | $3.01M | Buy |
48,419
+2,923
| +6% | +$181K | 0.12% | 118 |
|
|
2023
Q3 | $2.09M | Buy |
45,496
+887
| +2% | +$40.8K | 0.1% | 145 |
|
|
2023
Q2 | $2.56M | Sell |
44,609
-2,250
| -5% | -$129K | 0.11% | 113 |
|
|
2023
Q1 | $1.76M | Buy |
46,859
+2,263
| +5% | +$84.9K | 0.08% | 146 |
|
|
2022
Q4 | $1.25M | Buy |
44,596
+232
| +0.5% | +$6.5K | 0.06% | 183 |
|
|
2022
Q3 | $1.25M | Buy |
44,364
+1,425
| +3% | +$40.1K | 0.07% | 164 |
|
|
2022
Q2 | $1.49M | Sell |
42,939
-5,894
| -12% | -$205K | 0.08% | 120 |
|
|
2022
Q1 | $1.75M | Sell |
48,833
-14,726
| -23% | -$529K | 0.08% | 118 |
|
|
2021
Q4 | $1.48M | Buy |
63,559
+2,740
| +5% | +$63.8K | 0.06% | 134 |
|
|
2021
Q3 | $1.16M | Sell |
60,819
-1,008
| -2% | -$19.2K | 0.05% | 151 |
|
|
2021
Q2 | $1.25M | Buy |
+61,827
| New | +$1.25M | 0.05% | 139 |
|